|
More information on the common types of Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
New treatments for Hepatitis C
In 2011, the FDA approved two drugs for the treatment of Hepatitis C (HCV). These drugs must not be used as monotherapy and should only be used in combination with peginterferon alfa and ribavirin. This is commonly known as “tripletherapy”.
VICTRELIS™ (Boceprevir)
VICTRELIS™ (Boceprevir), a hepatitis C virus (HCV) protease inhibitor, which works by binding to the virus and preventing it from multiplying. Boceprevir is the first direct acting antiviral drug against the hepatitis C virus to be approved.
TELAPREVIR™ (Incivek)
TELAPREVIR™ (Incivek) is a highly-anticipated pill that is expected to have annual sales in the billions. It is approved for patients who have some liver damage from hepatitis C who either have not been treated, or were not cured by other drugs. Patients on Incivek take two pills three times per day.
From the Centers for Disease Control
|